Addex Therapeutics (ADXN) vs Xenetic Biosciences (XBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.6 million vs $5.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADXN | XBIO |
|---|---|---|
| Share price | $3.22 | $2.13 |
| Market cap | $5.64M | $4.99M |
| 1-day change | +1.21% | +0.47% |
| EPS (TTM) | $-7.56 | $-1.15 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $6.52 |
| 52-week low | $2.56 | $1.87 |
| Distance from 52-week high | -73.11% | -67.31% |
| Average volume | 138.20K | 88.61K |
| Shares outstanding | 1.75M | 2.34M |
| Employees | 3 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Xenetic Biosciences
XBIO stock →Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
ADXN vs XBIO FAQ
Which is bigger, Addex Therapeutics or Xenetic Biosciences?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.64M compared with $4.99M for Xenetic Biosciences (XBIO).
Are Addex Therapeutics and Xenetic Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.